Postherpetic Neuralgia
📧 Sign up to get email alerts when something new happens for Postherpetic Neuralgia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Y-4 to Treat the Postherpetic Neuralgia [Phase 2]
A Phase 2 clinical trial evaluating Y-4 for postherpetic neuralgia is currently recruiting. The study is sponsored by Neurodawn Pharmaceutic…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster [NA]
This clinical trial assesses whether venlafaxine can prevent postherpetic neuralgia in patients with acute herpes zoster. Recruitment is ong…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Dorsal Root Ganglion Stimulation in Postherpetic Neuropathy
Completed clinical trial of dorsal root ganglion stimulation for postherpetic neuralgia. The study is listed as completed on ClinicalTrials.…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Transcutaneous Auricular Vagus Nerve Stimulation on Post-Herpetic Neuralgia [NA]
A clinical trial evaluating transcutaneous auricular vagus nerve stimulation for postherpetic neuralgia is currently recruiting. The sponsor…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Transcranial Magnetic Stimulation for Chronic Neuropathic Pain [NA]
UCSF is conducting a trial evaluating transcranial magnetic stimulation for chronic neuropathic pain and related conditions; the study is cu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Study of ONO-1110 in Patients With Postherpetic Neuralgia [Phase 2]
Phase 2 clinical trial evaluating ONO-1110 for postherpetic neuralgia; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Erector Spinae Plane Block Versus Transcutaneous Radiofrequency in Postherpetic Neuralgia
An ongoing study is recruiting to compare erector spinae plane block with transcutaneous radiofrequency for postherpetic neuralgia. The cond…
-
FDA approval · 2026-02-24FDA Approved: PREGABALIN — Original Application (FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED)
FDA approved the original Abbreviated New Drug Application for pregabalin from Fourrts (India) Laboratories Private Limited, granting a gene…
-
FDA approval · 2026-02-17FDA Approved: GABAPENTIN — Supplemental Application (Creekwood Pharmaceuticals LLC)
The FDA approved a supplemental application for gabapentin filed by Creekwood Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Efficacy and Safety of LX9211 in Participants With Postherpetic Neuralgia [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of LX9211 in postherpetic neuralgia has completed, with results posted by the sponsor.
-
FDA approval · 2026-02-12FDA Approved: GABAPENTIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for gabapentin by Ascend Laboratories, LLC, updating regulatory approval for this generic product.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Postherpetic Neuralgia After Herpes Zoster and Incident Dementia Risk
This clinical trial update reports the completion of a study examining the relationship between Herpes Zoster, Postherpetic Neuralgia, and i…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Efficacy of Transcutaneous Pulsed Radiofrequency in Postherpetic Neuralgia
A clinical trial is recruiting to evaluate the efficacy of transcutaneous pulsed radiofrequency therapy for postherpetic neuralgia and relat…
-
FDA approval · 2026-02-02FDA Approved: PREGABALIN — Supplemental Application (Tris Pharma Inc)
FDA approves Tris Pharma Inc's supplemental application for pregabalin.
-
FDA approval · 2026-01-29FDA Approved: GABAPENTIN — Supplemental Application (Actavis Pharma, Inc.)
FDA granted a supplemental approval for gabapentin submitted by Actavis Pharma, Inc. The action represents a supplemental regulatory action …
-
FDA approval · 2026-01-29FDA Approved: GABAPENTIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Gabapentin from Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Predictors of Success After Intercostal Nerve Radiofrequency Treatment for Intercostal Neuralgia
A completed clinical trial update assessing factors that predict success of intercostal nerve radiofrequency treatment for intercostal neura…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Brain Stimulation for Postherpetic Neuralgia: A Randomized Sham-Controlled Trial [NA]
A randomized sham-controlled trial is planned to evaluate brain stimulation for treating postherpetic neuralgia, sponsored by Huazhong Unive…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Ultrasound-Guided Thoracic Paravertebral Block With Steroid and Local Anesthetic for Acute Herpes Zoster: Effects on Pain Control and Prevention of Postherpetic Neuralgia [Phase 3]
Phase 3 clinical trial evaluating ultrasound-guided thoracic paravertebral block with a steroid and local anesthetic for acute herpes zoster…
-
FDA approval · 2026-01-14FDA Approved: GABAPENTIN — Supplemental Application (Laurus Labs Limited)
FDA approved a supplemental application for gabapentin from Laurus Labs Limited (ANDA217965). This action approves the generic product for d…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Simultaneous Engagement of Networks for Alleviating Pain (SENAP) [Phase 1]
Phase 1 trial SENAP update indicating the study is not yet recruiting for neuropathic pain and postherpetic neuralgia.
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: The Analgesic Effect of Electroacupuncture on Postherpetic Neuralgia [NA]
A completed clinical trial assessing the analgesic effect of electroacupuncture for postherpetic neuralgia. The provided excerpt does not in…
-
FDA label_change · 2025-12-29FDA Approved: PREGABALIN — Supplemental Application (Cipla USA, Inc.)
FDA approved a supplemental application for Pregabalin submitted by Cipla USA, Inc., indicating changes to the drug's labeling. The notice d…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Effectiveness of Ultrasonography-Guided Serratus Posterior Superior Intercostal Plane Block in Thoracic Postherpetic Neuralgia: A Retrospective Cohort Study
A completed retrospective cohort study evaluating the effectiveness of an ultrasound-guided serratus posterior superior intercostal plane bl…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Establishment of a Prediction Model for Postherpetic Neuralgia
This clinical trial update reports the completion of a study aimed at establishing a prediction model for postherpetic neuralgia, potentiall…